en Experimental Neurobiology

Cited by CrossRef (6)

  1. Jagadeesh Kumar Dasappa, H. G. Nagendra. Preferential Selectivity of Inhibitors with Human Tau Protein Kinase Gsk3 Elucidates Their Potential Roles for Off-Target Alzheimer’s Therapy. International Journal of Alzheimer's Disease 2013;2013:1
    https://doi.org/10.1155/2013/809386
  2. Roy Yaari, Ann Hake. Alzheimer's disease clinical trials: past failures and future opportunities. Clinical Investigation 2015;5:297
    https://doi.org/10.4155/cli.14.127
  3. Deepshikha Bhardwaj, Connie Mitra, Chandrakala Aluganti Narasimhulu, Aladdin Riad, Mitsushita Doomra, Sampath Parthasarathy. Alzheimer's Disease—Current Status and Future Directions. Journal of Medicinal Food 2017;20:1141
    https://doi.org/10.1089/jmf.2017.0093
  4. Nobuaki Ohtake, Mieko Saito, Masaaki Eto, Kenjiro Seki. Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex. Regulatory Peptides 2014;190-191:1
    https://doi.org/10.1016/j.regpep.2014.04.003
  5. Dongmei Qi, Yongfa Qiao, Xin Zhang, Huijuan Yu, Bin Cheng, Haifa Qiao. AβDamages Learning and Memory in Alzheimer’s Disease Rats with Kidney-Yang Deficiency. Evidence-Based Complementary and Alternative Medicine 2012;2012:1
    https://doi.org/10.1155/2012/132829
  6. Nahla Mahgoub, George S. Alexopoulos. Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?. The American Journal of Geriatric Psychiatry 2016;24:239
    https://doi.org/10.1016/j.jagp.2015.12.003